![](/img/cover-not-exists.png)
Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular Degeneration
Philip J. Rosenfeld, Steven D. Schwartz, Mark S. Blumenkranz, Joan W. Miller, Julia A. Haller, James D. Reimann, William L. Greene, Naveed ShamsVolume:
112
Year:
2005
Language:
english
DOI:
10.1016/j.ophtha.2005.01.043
File:
PDF, 225 KB
english, 2005